For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
Scope of the Report:
This report focuses on the Blood Glucose Monitoring (BGM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.
The worldwide market for Blood Glucose Monitoring (BGM) is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 10900 million US$ in 2023, from 8270 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Becton
- Dickinson and Co.
- Terumo Corporation
- Acon Laboratories Inc.
- Roche Diagnostics Ltd.
- Johnson & Johnson
- ARKRAY Inc.
- Novo Nordisk A/S
- Medtronic
- Abbott Laboratories
- Bayer AG
- Ypsomed AG
- Sanofi
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Blood Glucose Meters
- Continuous Glucose Monitoring Devices
- Lancets
- Blood Glucose Testing Strips
Market Segment by Applications, can be divided into
- Hospital Use
- Clinic Use
- Household
- Other
There are 15 Chapters to deeply display the global Blood Glucose Monitoring (BGM) market.
Chapter 1, to describe Blood Glucose Monitoring (BGM) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Blood Glucose Monitoring (BGM), with sales, revenue, and price of Blood Glucose Monitoring (BGM), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Blood Glucose Monitoring (BGM), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Blood Glucose Monitoring (BGM) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Blood Glucose Monitoring (BGM) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source